Michael Sumner
Chief Medical Officer & Head of DevelopmentDr. Michael Sumner, also known as Mike, MD, MB BS, MBA, serves as Chief Medical Officer at Inovio Pharmaceuticals, Inc. since June 2022 and serves as its Head of Development since November 2025. He served as Chief Medical Officer of Orexo AB. since 2013 until June 2022. Dr. Sumner served as Senior Director of Clinical Affairs of Biopharmaceuticals of Novo Nordisk As. since January 31, 2005. He previously held numerous European- and US-based leadership roles at Novartis Pharmaceuticals and Shire Pharmaceuticals. Prior to joining Novo Nordisk, Dr. Sumner worked as senior medical Director for North America sales and marketing at Aventis Behring LLC. He is Member of Scientific Advisory Board at FirstString Research Incorporated. Dr. Sumner holds a Master of Business Administration from Henley Management College in the United Kingdom and received his medical degree from the University of London. He is a Member of the Royal College of Physicians.
Positions
- Company NameInovio Pharmaceuticals, Inc.Stock CodeINOPositionChief Medical Officer & Head of DevelopmentColleagues
- JEJacqueline E. SheaCEO, President & Director
- SXSimon X. BenitoIndependent Chairman of Board of Directors
- PDPeter D. KiesChief Financial Officer
- LMLaurent M. HumeauChief Scientific Officer & Chairman of the Scientific Advisory Board
- RLRobert L. CrottyGeneral Counsel, Corporate Secretary & Chief Compliance Officer
- WLWendy L. YarnoIndependent Director
- LSLota S. ZothIndependent Director
